YZS-model: A Predictive Model for Organic Drug Solubility Based on Graph Convolutional Networks and Transformer-Attention

The accurate prediction of drug molecule solubility is essential for determining their therapeutic effectiveness and safety, influencing the drug's ADME processes. Traditional solubility prediction techniques often fail to capture the complex nature of molecular tructures, leading to notable deviations between predictions and actual results. For example, the Discussion on Advanced Drug-Like Compound Structures. Lusci highlighted issues in capturing crucial cyclic structural information in molecules with ring structures. To overcome this issue, our research introduces a novel deep learning framework combining attention-based transformers, Long Short-Term Memory (LSTM) networks, and Graph Convolutional Networks (GCN), aimed at enhancing the precision of solubility predictions. Utilizing a training set of 9,943 compounds and testing on an anticancer compound dataset, our method achieved a correlation coefficient ($R^2$) of 0.55 and a Root Mean Square Error (RMSE) of 0.59, which outperforms the benchmark models' scores of 0.52 ($R^2$) and 0.61 (RMSE). Importantly, in an additional independent test, our model significantly outperformed the baseline with an RMSE of 1.05 compared to 1.28, a relative accuracy improvement of 45.9%. This research not only demonstrates the vast potential of deep learning for improving solubility prediction accuracy but also offers novel insights for drug design and selection in the future. Continued efforts will be directed towards optimizing the model architecture and extending its application to better support the drug development process, underscoring the pivotal role of deep learning in drug discovery.